Views & Analysis | Perspectives on pharma industry issues

Oncology

On GDF-15 neutralisation and cachexia, with CatalYm

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles

Personalised medicine at Roche

In this interview with Jaime del Barrio Seoane, Director General del Instituto Roche in Spain, he shares his views of personalised medicine adoption, barriers to adoption and when he expects personalised medicine to be part of clinical practice. The goal of personalised medicine is to achieve the best clinical results through the knowledge of the individual genetic profile...

Articles

KOL perspectives: Professor Tom Phillips

In the start of a new series gaining an insight to the opinions of KOLs we interview Professor Tom Phillips of the Western University of Health Sciences on his thoughts on a successful industry / KOL relationship. In this new series we seek to hear KOL’s perspectives on how they think they could best work with the pharma industry...

Articles

The case against creative pharma packaging

Chris Bekermeier shares six reasons as to why creative pharma packaging is not the best way to market pharmaceutical products. Branding and packaging are important in consumer products, from toys to potato chips to beer. However, an elaborate marketing and...

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital